New U.S. clinical trial outcomes indicate experimental therapy may not only work against small fiber neuropathy, but also improve chronic fatgue and quality of life in sarcoidosis. Lees verder Cibinetide (ARA 290) regenerates small nerve fibers
Six hospitals in the United States, the United Kingdom, Belgium and the Netherlands have started sharing care outcomes for sarcoidosis. Lees verder Best practices for sarcoidosis compared by leading international hospitals
A chronic fatigue rehab program with a combined biomedical and psychosocial approach has been proven to have a clinically relevant effectiveness for sarcoidosis patients in the Netherlands
Lees verder Successful new approach for sarcoidosis rehab in the Netherlands
Summaries of articles selected from the September 2013 issue of SarcoScoop, quarterly magazine of the Dutch sarcoidosis association. This issue’s theme: Nutrition
Could there be a future where electronic medicine is able to suppress overreactive inflammation and reduce neuropathic pain?
A new biological medicine against small fiber neuropathy is currently being tested on sarcoidosis patients in the Netherlands
How long before we will know the cause of sarcoidosis? A question to Swedish professor Johan Grunewald
Sarcoidosis (sar-koy-DO-sis) is a disease of unknown cause that leads to inflammation. This disease affects your body’s organs.